Release Date: 27/11/13 09:06 Summary: Daily share buy-back notice - Appendix 3E - 5000 Price Sensitive: No Download Document 34.94KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling